What Analysts Are Saying About Salesforce After Earnings

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What Analysts Are Saying About Salesforce After Earnings

© Thinkstock

Salesforce.com, Inc. (NYSE: CRM) reported fiscal third quarter financial results after markets closed Tuesday. While shares did take a step back in Wednesday’s session, analysts were still fairly positive following the report.

24/7 Wall St. has included some highlights from the earnings report, as well as what a few analysts are saying about the stock after the fact.

The company said that it had $0.39 in earnings per share (EPS) and $2.68 billion in revenue, compared with consensus estimates that called for $0.37 in EPS and $2.65 billion in revenue.

[nativounit]

Subscription and support revenues were $2.49 billion, an increase of 25% year-over-year. Professional services and other revenues were $194 million, an increase of 20%.

Deferred revenue totaled $4.39 billion, an increase of 26%, and 24% in constant currency. Unbilled deferred revenue totaled about $11.5 billion, up 34% from last year.

In terms of guidance for the coming quarter, the company expects to see EPS in the range of $0.32 to $0.33 and revenues in the range of $2.801 billion to $2.811 billion. There are consensus estimates calling for $0.34 in EPS and $2.79 billion in revenue for the fiscal fourth quarter.

Wedbush has an Outperform rating with a $123 price target, implying an upside of 13% from the most recent closing price $108.80. The firm detailed in its report:

We expect Salesforce to sustain its strong momentum and margin expansion, as it capitalizes on its industry-leading CRM product portfolio to gain enterprise wallet share in a large TAM [total addressable market]. Salesforce delivered a big 3Q billings beat, driven by sustained growth in Sales Cloud (+17%), acceleration in Service Cloud (+25%, up from +21% last quarter), and international expansion… Moreover, the gap between Salesforce.com and broad-line competitors in the CRM market appears to be widening, not narrowing, especially as Salesforce deepens its industry specialization, geographic reach, and partner relationships. Valuation looks attractive given our outlook for 21% revenue growth and 150 basis points of annual margin expansion on a ratable model.

Oppenheimer has an Outperform rating with a $125 price target, implying upside of 15%. Oppenheimer had this to say about Salesforce:

We are increasing our price target to $125 (from $100) on Salesforce shares following another quarter of solid results from the business. Management also reaffirmed the FY2019 revenue growth guidance of ~20% given on November 6th which we see limiting risks to estimates in F4Q, and foretelling another strong growth year for the business in 2018. We believe the fundamental outlook for the business is positive. On balance, Americas growth decelerated for the third straight quarter. Bottom Line: We see CRM shares as one of the best long-term growth investments for the powerful digital-transformations spending wave permeating the enterprise market, and it should be a core holding for large-cap growth investors who believe in nextgeneration cloud, data analytics, AI, and mobile technology.

A few other analysts weighed in on Salesforce after earnings as well:

  • Canaccord Genuity has a Buy rating with a $130 price target.
  • Roth Capital has a Neutral rating.
  • Bernstein has an Underperform rating with an $89 price target.
  • SunTrust has a Buy rating with a $122 price target.
  • Wells Fargo has an Outperform rating with a $130 price target.
  • Pivotal Research has a Hold rating with a $96 price target.

Shares of Salesforce were last seen down about 2% at $106.29, with a consensus analyst price target of $115.59 and a 52-week range of $66.43 to $109.19.

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618